First Manhattan Co. Llc.
Source: SEC Form 13F · as of Mar 2026First Manhattan Co. Llc. holds 12 biotech & pharma companies tracked by BioSniper, totaling $21.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
12
Total value held
$21.4M
BioSniper AIPage context preserved
Prepared research question
What matters most for GILEAD SCIENCES, INC. (GILD)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| GILDGILEAD SCIENCES, INC. | 74,939 | $10.4M |
| OGNOrganon & Co. | 950,172 | $5.7M |
| DMACDiaMedica Therapeutics Inc. | 455,000 | $3.1M |
| TEVATeva Pharmaceutical Industries Limited | 43,675 | $1.3M |
| ROIVRoivant Sciences Ltd. | 11,146 | $309K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 3,941 | $219K |
| IOVAIOVANCE BIOTHERAPEUTICS, INC. | 28,998 | $102K |
| ABUSArbutus Biopharma Corp | 14,000 | $63K |
| OPKOPKO HEALTH, INC. | 52,150 | $59K |
| ALDXAldeyra Therapeutics, Inc. | 34,745 | $59K |
| OVIDOvid Therapeutics Inc. | 26,000 | $58K |
| CALCCalciMedica, Inc. | 13,226 | $7K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.